会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Pharmaceutical composition for angiotensin II-mediated diseases
    • 用于血管紧张素II介导的疾病的药物组合物
    • US06420405B2
    • 2002-07-16
    • US09783579
    • 2001-02-15
    • Yoshiyuki InadaKeiji Kubo
    • Yoshiyuki InadaKeiji Kubo
    • A61K3141
    • A61K45/06A61K31/495A61K31/54A61K31/415A61K2300/00
    • This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula wherein R1 is H or an optionally substituted hydrocarbon residue; R2 is an optionally esterified carboxyl group; R3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R2; and Y is a bond, —O—, —S(O)m- (wherein m is 0, 1 or 2) or —N(R4)— (wherein R4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.
    • 本发明涉及一种用于血管紧张素II介导的疾病的药物组合物,其包含具有血管紧张素II拮抗活性的化合物,其中R 1为H或任选取代的烃残基; R2是任选酯化的羧基; R3是能够形成阴离子或可转换的基团的基团; X是相邻的亚苯基和苯基之间的线性部分的2个苯环或链长为1〜2个原子的间隔基之间的共价键; n为1或2; 环A是除了R2之外具有1或2个任选取代基的苯环; 并且Y是键,-O - , - S(O)m - (其中m是0,1或2)或-N(R 4) - (其中R 4是H或任选取代的烷基) 其可接受的盐与具有利尿活性的化合物或具有钙拮抗作用的化合物组合。
    • 4. 发明授权
    • Pharmaceutical composition for angiotensin II-mediated diseases
    • 用于血管紧张素II介导的疾病的药物组合物
    • US06228874B1
    • 2001-05-08
    • US09563855
    • 2000-05-04
    • Yoshiyuki InadaKeiji Kubo
    • Yoshiyuki InadaKeiji Kubo
    • A61K3141
    • A61K45/06A61K31/495A61K31/54A61K31/415A61K2300/00
    • This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula wherein R1 is H or an optionally substituted hydrocarbon residue; R2 is an optionally esterified carboxyl group; R3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R2; and Y is a bond, —O—, —S(O)m— (wherein m is 0, 1 or 2) or —N(R4)— (wherein R4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.
    • 本发明涉及一种用于血管紧张素II介导的疾病的药物组合物,其包含具有血管紧张素II拮抗活性的化合物,其中R 1为H或任选取代的烃残基; R2是任选酯化的羧基; R3是能够形成阴离子或可转换的基团的基团; X是相邻的亚苯基和苯基之间的线性部分的2个苯环或链长为1〜2个原子的间隔基之间的共价键; n为1或2; 环A是除了R2之外具有1或2个任选取代基的苯环; 并且Y是键,-O - , - S(O)m - (其中m是0,1或2)或-N(R 4) - (其中R 4是H或任选取代的烷基) 其可接受的盐与具有利尿活性的化合物或具有钙拮抗作用的化合物组合。
    • 5. 发明授权
    • Pharmaceutical composition for angiotensin II-mediated diseases
    • 用于血管紧张素II介导的疾病的药物组合物
    • US5958961A
    • 1999-09-28
    • US883040
    • 1997-06-26
    • Yoshiyuki InadaKeiji Kubo
    • Yoshiyuki InadaKeiji Kubo
    • A61K31/495A61K31/54A61K45/06A61K31/415A61K31/41
    • A61K45/06A61K31/495A61K31/54
    • This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula ##STR1## wherein R.sup.1 is H or an optionally substituted hydrocarbon residue; R.sup.2 is an optionally esterified carboxyl group; R.sup.3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R.sup.2 ; and Y is a bond, --O--, --S(O)m- (wherein m is 0, 1 or 2) or --N(R.sup.4)-- (wherein R.sup.4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.
    • 本发明涉及一种用于血管紧张素II介导的疾病的药物组合物,其包含具有下式的血管紧张素II拮抗活性的化合物:其中R 1为H或任选取代的烃残基; R2是任选酯化的羧基; R3是能够形成阴离子或可转换的基团的基团; X是相邻的亚苯基和苯基之间的线性部分的2个苯环或链长为1〜2个原子的间隔基之间的共价键; n为1或2; 环A是除了R2之外具有1或2个任选取代基的苯环; 并且Y是键,-O - , - S(O)m - (其中m是0,1或2)或-N(R 4) - (其中R 4是H或任选取代的烷基) 其可接受的盐与具有利尿活性的化合物或具有钙拮抗作用的化合物组合。
    • 6. 发明授权
    • Pharmaceutical composition for angiotensin II-mediated diseases
    • 用于血管紧张素II介导的疾病的药物组合物
    • US5721263A
    • 1998-02-24
    • US351011
    • 1994-12-07
    • Yoshiyuki InadaKeiji Kubo
    • Yoshiyuki InadaKeiji Kubo
    • A61K31/495A61K31/54A61K45/06A61K31/41A61K31/50
    • A61K45/06A61K31/495A61K31/54
    • This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula ##STR1## wherein R.sup.1 is H or an optionally substituted hydrocarbon residue; R.sup.2 is an optionally esterified carboxyl group; R.sup.3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R.sup.2 ; and Y is a bond, --O--, --S(O)m-- (wherein m is 0, 1 or 2) or --N(R.sup.4)-- (wherein R.sup.4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.
    • 本发明涉及一种用于血管紧张素II介导的疾病的药物组合物,其包含具有式IMAMA的血管紧张素II拮抗活性的化合物,其中R 1为H或任选取代的烃残基; R2是任选酯化的羧基; R3是能够形成阴离子或可转换的基团的基团; X是相邻的亚苯基和苯基之间的线性部分的2个苯环或链长为1〜2个原子的间隔基之间的共价键; n为1或2; 环A是除了R2之外具有1或2个任选取代基的苯环; 并且Y是键,-O - , - S(O)m - (其中m是0,1或2)或-N(R 4) - (其中R 4是H或任选取代的烷基) 其可接受的盐与具有利尿活性的化合物或具有钙拮抗作用的化合物组合。